rs375328916

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_004463.3(FGD1):​c.2619C>T​(p.Phe873Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000141 in 1,209,196 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000010 ( 0 hom. 6 hem. )

Consequence

FGD1
NM_004463.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.470

Publications

2 publications found
Variant links:
Genes affected
FGD1 (HGNC:3663): (FYVE, RhoGEF and PH domain containing 1) This gene encodes a protein that contains Dbl (DH) and pleckstrin (PH) homology domains and is similar to the Rho family of small GTP-binding proteins. The encoded protein specifically binds to the Rho family GTPase Cdc42Hs and can stimulate the GDP-GTP exchange of the isoprenylated form of Cdc42Hs. It also stimulates the mitogen activated protein kinase cascade leading to c-Jun kinase SAPK/JNK1 activation. Defects in this gene are the cause of the faciogenital dysplasia in Aarskog-Scott syndrome and a syndromatic form of X-linked cognitive disability. [provided by RefSeq, Jul 2017]
TSR2 (HGNC:25455): (TSR2 ribosome maturation factor) The protein encoded by this gene appears to repress the transcription of NF-kappaB and may be involved in apoptosis. Defects in this gene are a cause of Diamond-Blackfan anemia. [provided by RefSeq, Oct 2016]
TSR2 Gene-Disease associations (from GenCC):
  • Diamond-Blackfan anemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Diamond-Blackfan anemia 14 with mandibulofacial dysostosis
    Inheritance: XL Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant X-54446376-G-A is Benign according to our data. Variant chrX-54446376-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 585860.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.47 with no splicing effect.
BS2
High AC in GnomAd4 at 6 AD,XL gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FGD1NM_004463.3 linkc.2619C>T p.Phe873Phe synonymous_variant Exon 18 of 18 ENST00000375135.4 NP_004454.2 P98174A0A024R9Y5
TSR2NM_058163.3 linkc.*1826G>A 3_prime_UTR_variant Exon 5 of 5 ENST00000375151.5 NP_477511.1 Q969E8A0A024R9U9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FGD1ENST00000375135.4 linkc.2619C>T p.Phe873Phe synonymous_variant Exon 18 of 18 1 NM_004463.3 ENSP00000364277.3 P98174
TSR2ENST00000375151.5 linkc.*1826G>A 3_prime_UTR_variant Exon 5 of 5 1 NM_058163.3 ENSP00000364293.4 Q969E8

Frequencies

GnomAD3 genomes
AF:
0.0000534
AC:
6
AN:
112315
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000194
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000337
AC:
6
AN:
177843
AF XY:
0.0000632
show subpopulations
Gnomad AFR exome
AF:
0.000157
Gnomad AMR exome
AF:
0.0000739
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000100
AC:
11
AN:
1096881
Hom.:
0
Cov.:
31
AF XY:
0.0000166
AC XY:
6
AN XY:
362335
show subpopulations
African (AFR)
AF:
0.0000758
AC:
2
AN:
26393
American (AMR)
AF:
0.0000854
AC:
3
AN:
35117
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19340
East Asian (EAS)
AF:
0.0000331
AC:
1
AN:
30189
South Asian (SAS)
AF:
0.0000745
AC:
4
AN:
53687
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40407
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4126
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841587
Other (OTH)
AF:
0.00
AC:
0
AN:
46035
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000534
AC:
6
AN:
112315
Hom.:
0
Cov.:
23
AF XY:
0.0000290
AC XY:
1
AN XY:
34501
show subpopulations
African (AFR)
AF:
0.000194
AC:
6
AN:
30923
American (AMR)
AF:
0.00
AC:
0
AN:
10648
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2657
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3543
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2723
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6198
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53185
Other (OTH)
AF:
0.00
AC:
0
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000378

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 27, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Dec 06, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
1.8
DANN
Benign
0.87
PhyloP100
0.47
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375328916; hg19: chrX-54472809; COSMIC: COSV64308336; COSMIC: COSV64308336; API